JP2006526639A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006526639A5 JP2006526639A5 JP2006514972A JP2006514972A JP2006526639A5 JP 2006526639 A5 JP2006526639 A5 JP 2006526639A5 JP 2006514972 A JP2006514972 A JP 2006514972A JP 2006514972 A JP2006514972 A JP 2006514972A JP 2006526639 A5 JP2006526639 A5 JP 2006526639A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody fragment
- group
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/452,593 US20040258699A1 (en) | 2002-02-11 | 2003-06-02 | Immunotherapeutics for biodefense |
| PCT/US2004/016557 WO2004110362A2 (en) | 2003-06-02 | 2004-05-26 | Immunotherapeutics for biodefense |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006526639A JP2006526639A (ja) | 2006-11-24 |
| JP2006526639A5 true JP2006526639A5 (https=) | 2007-06-28 |
Family
ID=33551270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006514972A Withdrawn JP2006526639A (ja) | 2003-06-02 | 2004-05-26 | 生物防御のための免疫療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040258699A1 (https=) |
| EP (1) | EP1648487A2 (https=) |
| JP (1) | JP2006526639A (https=) |
| KR (1) | KR20060031803A (https=) |
| CN (1) | CN1829525A (https=) |
| AU (1) | AU2004247034A1 (https=) |
| CA (1) | CA2527843A1 (https=) |
| IL (1) | IL172231A0 (https=) |
| WO (1) | WO2004110362A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002046228A2 (en) * | 2000-12-05 | 2002-06-13 | Wisconsin Alumni Research Foundation | Receptor for b. anthracis toxin |
| US7658924B2 (en) * | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| US7601351B1 (en) | 2002-06-26 | 2009-10-13 | Human Genome Sciences, Inc. | Antibodies against protective antigen |
| WO2004052277A2 (en) * | 2002-12-05 | 2004-06-24 | Wisconsin Alumni Research Foundation | Anthrax antitoxins |
| WO2005007804A2 (en) * | 2003-04-10 | 2005-01-27 | President And Fellows Of Harvard College | Anthrax conjugate vaccine and antibodies |
| ES2376337T3 (es) * | 2004-03-03 | 2012-03-13 | Iq Therapeutics Bv | Anticuerpos monoclonales neutralizantes de la toxina del �?ntrax humanos y métodos para su uso. |
| CA2591665C (en) * | 2004-12-20 | 2015-05-05 | Crucell Holland B.V. | Binding molecules capable of neutralizing west nile virus and uses thereof |
| US7838252B2 (en) * | 2005-02-17 | 2010-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating a subject having an anthrax toxin mediated condition |
| WO2008063147A2 (en) * | 2005-03-31 | 2008-05-29 | The General Hospital Corporation | Anthrax polypeptide binding |
| WO2006120230A2 (en) | 2005-05-12 | 2006-11-16 | Crucell Holland B.V. | Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| US20070202117A1 (en) * | 2005-12-22 | 2007-08-30 | Herman Groen | Compositions and Methods Of Modulating the Immune Response |
| US7794732B2 (en) | 2006-05-12 | 2010-09-14 | Oklahoma Medical Research Foundation | Anthrax compositions and methods of use and production |
| CA2881717C (en) * | 2006-06-06 | 2018-06-12 | Cecilia Anna Wilhelmina Geuijen | Human binding molecules having killing activity against staphylococci and uses thereof |
| WO2008042261A2 (en) * | 2006-09-28 | 2008-04-10 | Elusys Therapeutics, Inc. | Anti-anthrax antibody, formulations thereof, and methods of use |
| EP1913955A1 (en) | 2006-10-19 | 2008-04-23 | Gerhard, Markus | Novel method for treating H.pylori infections |
| US8540987B2 (en) * | 2008-01-29 | 2013-09-24 | Institute For Antibodies Co., Ltd. | Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody |
| JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
| GB0812316D0 (en) * | 2008-07-07 | 2008-08-13 | Secr Defence | Antibody |
| US8343495B2 (en) * | 2009-01-10 | 2013-01-01 | Auburn University | Equine antibodies against Bacillus anthracis for passive immunization and treatment |
| CN103172734A (zh) * | 2013-04-07 | 2013-06-26 | 中国人民解放军南京军区军事医学研究所 | 人源抗炭疽毒素保护性抗原中和抗体Fab及应用 |
| TWI606834B (zh) * | 2014-10-24 | 2017-12-01 | 國立陽明大學 | 缺氧培養之間葉幹細胞用於修復血管內皮細胞的應用 |
| CN104628853B (zh) * | 2015-02-06 | 2017-10-10 | 中国人民解放军南京军区军事医学研究所 | 人源抗炭疽保护性抗原PA的抗体IgG及其应用 |
| US11013815B2 (en) | 2017-06-14 | 2021-05-25 | Monojul, Llc | High-affinity anti-human folate receptor beta antibodies and methods of use |
| CN109081869B (zh) | 2018-08-28 | 2022-06-03 | 东莞市朋志生物科技有限公司 | Ns1蛋白的结合蛋白 |
| CN109134647B (zh) | 2018-08-28 | 2020-08-04 | 东莞市朋志生物科技有限公司 | Ns1蛋白的结合蛋白 |
| WO2023003679A1 (en) * | 2021-07-22 | 2023-01-26 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Single domain antibodies that bind and neutralize venezuelan equine encephalitis virus |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1278764A4 (en) * | 2000-05-04 | 2004-05-19 | Harvard College | CONNECTIONS AND METHODS FOR TREATING AND PREVENTING BACTERIAL INFECTIONS (11/14/01) |
| US20040009178A1 (en) * | 2002-02-11 | 2004-01-15 | Bowdish Katherine S. | Immunotherapeutics for biodefense |
-
2003
- 2003-06-02 US US10/452,593 patent/US20040258699A1/en not_active Abandoned
-
2004
- 2004-05-26 KR KR1020057023203A patent/KR20060031803A/ko not_active Withdrawn
- 2004-05-26 CA CA002527843A patent/CA2527843A1/en not_active Abandoned
- 2004-05-26 EP EP04776122A patent/EP1648487A2/en not_active Withdrawn
- 2004-05-26 WO PCT/US2004/016557 patent/WO2004110362A2/en not_active Ceased
- 2004-05-26 JP JP2006514972A patent/JP2006526639A/ja not_active Withdrawn
- 2004-05-26 CN CNA2004800215188A patent/CN1829525A/zh active Pending
- 2004-05-26 AU AU2004247034A patent/AU2004247034A1/en not_active Abandoned
-
2005
- 2005-11-28 IL IL172231A patent/IL172231A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006526639A5 (https=) | ||
| JP6622363B2 (ja) | 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ | |
| JP6216926B2 (ja) | オランザピンに対する抗体及びその使用 | |
| Gevaert et al. | Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue | |
| CN105378099B (zh) | Hcv核心脂质结合结构域单克隆抗体 | |
| JP2020143059A (ja) | リスペリドンへの抗体及びその使用 | |
| JP6242893B2 (ja) | クエチアピンに対する抗体及びその使用 | |
| JP2002521391A5 (https=) | ||
| CN104736561B (zh) | 帕潘立酮的抗体及其用途 | |
| JP2007536932A5 (https=) | ||
| RU2010117018A (ru) | Антитела к gdf8 и их применения | |
| JP2011528561A5 (https=) | ||
| JP2006523453A5 (https=) | ||
| JP2010511177A5 (https=) | ||
| JP2005529587A5 (https=) | ||
| RU2013109173A (ru) | АНТИТЕЛА ПРОТИВ IgG1 ЧЕЛОВЕКА | |
| JP2017506505A5 (https=) | ||
| JP2015530868A5 (https=) | ||
| WO2015107171A1 (en) | Methods of identifying patients suffering from liver cancer who will most likely benefit from a treatment with an antagonist anti-fgfr4 antibody | |
| JP2019531716A5 (https=) | ||
| EP2332988A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| TW201018486A (en) | Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (APH) and anaplasma platys (APL) | |
| JP2007513873A5 (https=) | ||
| Didier et al. | Monoclonal antibodies neutralize Bacillus cereus Nhe enterotoxin by inhibiting ordered binding of its three exoprotein components | |
| WO2022093641A1 (en) | Anti-nkg2a agents and compositions and methods for making and using the same |